Scientists find blood signatures for aggressive prostate cancer

LONDON (Reuters) – Scientists have found two distinct genetic “signatures” for prostate cancer that may help doctors predict which patients have aggressive tumors, and designed experimental blood tests to read those genetic signs like barcodes. The teams, whose work was published on Tuesday in the Lancet Oncology journal, believe tests developed from the signatures could eventually be used to tell which patients need immediate treatment. …

Continue Reading